'Drill, Baby, Drill!' New Project Announced in the Gulf of America
So, That's Why a New Mexico Judge Had to Resign
Trump Speaks Out on Effort to Change Name of Massapequa Chiefs
'Totally Unacceptable': This Lawmaker Just Became the First Republican to Call for Pete...
Have You Heard of This 'Dark Woke' Phenomenon?
Proposed Iowa Gun Law Sparks Debate That Shouldn't Be a Debate
Everyone Needs to Cut RFK Jr. a Break
Jamie Raskin Vows Revenge On Foreign Leaders Who Work With Trump
Youngkin’s Crackdown: Over 500 Criminal Illegal Immigrants, Gang Members Swept Off Virgini...
President Trump the ‘Right Man at the Right Time,’ Mark Levin Tells Sen....
Trump, Melania Bring Class Back to the White House Easter Egg Roll
'Faith, Family, and Freedom': How This Year's White House Easter Egg Roll Was...
UPDATE: El Salvador Blocks Four U.S. Democrats from Meeting with Deported MS-13 Suspect
House Oversight Committee Chairman James Comer Recommends Andrew Cuomo for Criminal Prosec...
One Group of Illegal Aliens Afraid of Deportation Are Leaving the US and...
Tipsheet

'Revolving Door': What the WH Left Out of Its Announcement About Nominee for NIH Director

President Biden on Monday nominated Dr. Monica Bertagnolli, a surgical oncologist and head of the National Cancer Institute, to be the next director of the National Institutes of Health, but critics say the White House left out an important detail about her background in the administration’s announcement.  

Advertisement

“Dr. Bertagnolli has spent her career pioneering scientific discovery and pushing the boundaries of what is possible to improve cancer prevention and treatment for patients, and ensuring that patients in every community have access to quality care,” Biden said in a statement.
 
“As Director of the National Cancer Institute, Dr. Bertagnolli has advanced my Cancer Moonshot to end cancer as we know it. She has brought together partners and resources from different sectors to launch groundbreaking efforts in cancer prevention and early detection, a national navigation program for childhood cancers, and additional programs to bring clinical trials to more Americans,” the statement continued. “Dr. Bertagnolli is a world-class physician-scientist whose vision and leadership will ensure NIH continues to be an engine of innovation to improve the health of the American people.” 

As Democratic presidential candidate Robert F. Kennedy Jr. and others pointed out, she’s a “revolving door” nominee. 

“From 2015-2021, Bertagnolli received more than 116 grants from Pfizer, totaling $290.8 million. This amount made up 89% of all her. research grants,” he tweeted. 

Kennedy was sure to point out this doesn’t automatically make her “personally corrupt,” but that she will champion Big Pharma’s viewpoints.  

Advertisement

“That is how agencies are captured,” he added, commenting later that he was not surprised the White House left this detail out of the announcement. 


Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement